Key points from article :
Urine test if developed successfully could increase longer-term survival rates to 60 per cent.
Test measures levels of 3 proteins found in urine, identified as biomarkers of early-stage pancreatic cancer.
Biomarkers will now be tested in a £1.6 million clinical study of more than 3,000 people.
Study is funded by medical research charity Pancreatic Cancer Research Fund.
Non-invasive test is developed by Professor Crnogorac-Jurcevic of Barts Cancer Institute.
